NRG-LU003

A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients: The NCI-NRG ALK Master Protocol
Contact phone
Clinical Trials Office – 517-364-9400
Principal investigator
Gordan Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Lung